Intervention Review

Rituximab for relapsing-remitting multiple sclerosis

  1. Dian He1,
  2. Rui Guo2,
  3. Fubo Zhang3,
  4. Chao Zhang4,
  5. Shuai Dong2,
  6. Hongyu Zhou5,*

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 6 DEC 2013

Assessed as up-to-date: 9 AUG 2013

DOI: 10.1002/14651858.CD009130.pub3

How to Cite

He D, Guo R, Zhang F, Zhang C, Dong S, Zhou H. Rituximab for relapsing-remitting multiple sclerosis. Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD009130. DOI: 10.1002/14651858.CD009130.pub3.

Author Information

  1. 1

    Affiliated Hospital of Guiyang Medical College, Department of Neurology, Guiyang, Guizhou Province, China

  2. 2

    Jinan No. 6 People's Hospital, Department of Neurology, Jinan, Shandong Province, China

  3. 3

    Cangzhou City Cemtral Hospital, Department of Neurology, Cangzhou, Hebei Province, China

  4. 4

    Jinan No. 6 People's Hospital, Department of Internal Medicine, Jinan, Shandong Province, China

  5. 5

    West China Hospital, Sichuan University, Department of Neurology, Chengdu, Sichuan, China

*Hongyu Zhou, Department of Neurology, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 6 DEC 2013


Cited in:


This article has been cited by:

  1. 1
    Morten Haugen, Jette L. Frederiksen, Matilda Degn, B cell follicle-like structures in multiple sclerosis—With focus on the role of B cell activating factor, Journal of Neuroimmunology, 2014, 273, 1-2, 1